An injection device (100) for the injection of a controlled dose of an injectable substance, including: one containment chamber (33) of the injectable substance, defined inside a tubular body (3); a plunger (5) slidingly engaged inside the tubular body (3), provided with a central stem (53) placed between a cap (51) and a base (52); a spacer applied to the plunger (5) and adapted to allow a forward movement of the plunger (5) in the containment chamber (33) up to reach an abutment of the spacer between the base (52) of the plunger (5) and the second end (32) of the containment body (3) to prevent the further forward movement of the plunger (5) in the containment chamber (33). The injection device (100) is characterized in that the spacer is a flexible dosing label (9), that can be deformed in one longitudinal direction (X) and rigid in one transverse direction (Y).

The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

A dose setting mechanism for a drug delivery device includes a primary drug delivery assembly and a secondary drug delivery assembly. The dose setting mechanism includes a primary dose dial component for setting a dose in the primary drug delivery assembly and a secondary dose dial component for setting a dose in the secondary drug delivery assembly. The primary dose dial component and the secondary dose dial component are configured to rotate during dose setting. A gear mechanism is configured such that in a first phase of the dose setting, rotation of the primary dose dial component is transferred to the secondary dose dial component and such that in a second phase of the dose setting, the secondary dose dial component is decoupled from the primary dose dial component such that rotation of the primary dose dial component is prevented from being transferred to the secondary dose dial component.

A device for delivery of medicament is presented that has an elongated housing, a container mounted within the housing and adapted to contain liquid medicament, a stopper slidably arranged within said container, and a delivery mechanism comprising a resilient member, a plunger assembly having one end connected to the stopper and a second end being operably connected to the resilient member, a rotatable latch for releasably retaining the plunger assembly in a first position where the resilient member has an accumulated energy, where rotation of the latch releases the plunger assembly such that the accumulated energy is transferred to the plunger assembly for driving the stopper within the container whereby the medicament within said container is delivered to an injection site. After delivery of the medicament a rotator having a hard stop feature aligns with a rib on the protective shield to prevent retraction of the protective shield.

A handheld injection device includes a housing containing a cartridge, a dose setting means being operable in a first direction to set a desired dose to be dispensed, a piston rod being adapted to cooperate with a piston so as to cause a set dose to be injected from the cartridge, and a first clicker component, which is largely rotationally constrained to the housing, and a second clicker component, which is rotatable relative to the housing during dose dispensing. The clicker components are adapted to contact each other only at the end of dispensing of a set dose to thereby provide an audible and/or tactile first feedback to a user. The first clicker component is displaceable relative to the housing between a proximal dose setting position and a distal dose dispensing position.

A single use medical device can include a single use medical device module configured for use in a medical procedure. The single use medical device can also include an electronic component having a one-time programmable (OTP) component that is configured to render the single use medical device module unusable after being used in the medical procedure in the subject. The single use medical device can also include a self-sacrificing module (SSM) that is configured to self-destruct and render the single use medical device unusable upon being cleaned or sterilized after being used in the medical procedure in the subject. The SSM can be operably coupled with a system controller module (SCM), which can read the state of the SSM and determine whether or not the medical device has undergone cleaning or sterilization.

A syringe includes a barrel having a proximal end, a distal end having a distal tip defining a channel, and a sidewall extending between the proximal end and the distal end. The syringe also includes a tip cap removably connected to the distal tip of the barrel restricting fluid flow from the channel. The tip cap includes a connector configured to receive the distal tip of the barrel forming a friction engagement with the distal tip, a cap shield connected to and extending about the connector, and a release tab extending proximally from the cap shield that secures the tip cap to the barrel. A prefilled flushing syringe including a predetermined volume of a fluid disposed within the barred of the syringe, as well as methods for expulsion of fluid from the syringe and of assembling the syringe and tip cap are also disclosed herein.

There is provided inter alia an aqueous liquid pharmaceutical formulation comprising (i) an insulin compound, (ii) ionic zinc, (iii) a zinc binding species at a concentration of 1 mM or more selected from species having a log K with respect to zinc ion binding in the range 4.5-12.3 at 25? C., and (iv) a non-ionic surfactant which is an alkyl glycoside; and wherein the formulation is substantially free of EDTA and any other zinc binding species having a log K with respect to zinc ion binding of more than 12.3 at 25? C.

A drug delivery device for dispensing of a dose of a medicament includes an elongated body extending in an axial direction, a cartridge holder to accommodate a cartridge at least partially filled with the medicament and having an axially displaceable piston, and a piston rod to operably engage with the piston of the cartridge to displace the piston in axial distal direction. The drug delivery device further includes a coupling member connected with the cartridge holder and being axially displaceably arranged in the body for retracting the cartridge holder into the body during setting of a dose.

An apparatus comprises a body having an opening at a first end of the body. A plunger control grip is slidably coupled to a portion of the body circumference and configured to couple to a syringe plunger. The apparatus further comprises a cover pivotably coupled to the first end of the body, wherein in an open position the cover exposes a cavity configured to receive a syringe. A locking mechanism is pivotally secured to the cover, wherein the locking mechanism is configured to prevent forward movement of the plunger control grip when in a locked position and to enable forward movement of the plunger control grip when in an unlocked position. The unlocked position is activated by external contact with the locking mechanism and forward movement is in the direction toward the first end of the body.